Value-Based Myeloma Care & New Therapies – Dr. Matias Sanchez
- Insights from the IVBM event on standardizing procedures and leveraging telehealth for cost-effective care.
- The shift from broad chemotherapy regimens to targeted treatments, such as chimeric antigen receptor (CAR) T-cell therapy and bispecific antibodies,has significantly improved overall survival and quality of life...
- Matias Sanchez,MD,a hematologist-oncologist at university of Illinois Health and assistant professor of medicine in the Division of Hematology and Oncology at the University of Illinois College of Medicine,highlighted...
Okay, I’ve reviewed the provided text and will create a extensive, SEO-optimized, and informative article based on the guidelines.“`html
Strategies to Optimize the cost and Delivery of Novel Therapies for Multiple Myeloma
Table of Contents
- Strategies to Optimize the cost and Delivery of Novel Therapies for Multiple Myeloma
- at a Glance
- The challenge of Balancing Cost and Care in Multiple Myeloma Treatment
- Standardization as a Foundation for Quality Improvement
- Rush University Medical Center’s Telehealth Monitoring Program
- The Need for Reimbursement of Telehealth Monitoring
- Strategies for cost Optimization in Multiple Myeloma Treatment
Insights from the IVBM event on standardizing procedures and leveraging telehealth for cost-effective care.
The challenge of Balancing Cost and Care in Multiple Myeloma Treatment
The shift from broad chemotherapy regimens to targeted treatments, such as chimeric antigen receptor (CAR) T-cell therapy and bispecific antibodies,has significantly improved overall survival and quality of life for patients with multiple myeloma. However, thes advanced therapies come with ample costs, creating challenges for healthcare systems, clinicians, laboratories, and payers.
Matias Sanchez,MD,a hematologist-oncologist at university of Illinois Health and assistant professor of medicine in the Division of Hematology and Oncology at the University of Illinois College of Medicine,highlighted the need for innovative approaches to manage these costs while maintaining high-quality patient care during a presentation at the International Workshop on Waldenström’s Macroglobulinemia (IVBM).
Standardization as a Foundation for Quality Improvement
Dr. Sanchez emphasized that standardizing procedures is a crucial first step in optimizing the use of novel therapies.By establishing clear, consistent protocols, healthcare providers can reduce variability in treatment and improve efficiency.
Once procedures are standardized, healthcare systems can implement quality improvement projects to further refine processes and enhance patient outcomes.This iterative approach allows for continuous learning and adaptation as new evidence emerges and technologies evolve.
Rush University Medical Center’s Telehealth Monitoring Program
Dr. Sanchez highlighted the innovative strategies being implemented at Rush University Medical Center. One example is their use of outpatient telehealth monitoring for patients receiving bispecific antibodies.
This program provides patients with a telehealth monitor to track fever and vital signs at home. This allows for early detection of potential complications, such as cytokine release syndrome (CRS), a common side effect of bispecific antibody therapy, and enables timely intervention, perhaps preventing hospitalizations and reducing overall costs.
The Need for Reimbursement of Telehealth Monitoring
The success of telehealth monitoring programs hinges on appropriate reimbursement. Dr. Sanchez argued that payers shoudl recognize the value of these programs and provide adequate compensation for the services provided.
Reimbursement for telehealth monitoring would incentivize healthcare systems to adopt these innovative approaches, ultimately leading to improved patient outcomes and reduced healthcare costs. This requires a collaborative effort between clinicians, payers, and policymakers to develop sustainable reimbursement models.
Strategies for cost Optimization in Multiple Myeloma Treatment
- Standardized Treatment Protocols: Implementing clear and consistent guidelines for the use of novel therapies.